Testing effectiveness (Phase 2)Not Yet RecruitingNCT06544460
What this trial is testing
Secondary Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for PARP Inhibitors Resistance Patients
Who this might be right for
Ovarian Cancer
Fudan University 94